新冠疫情时代下的印度结核病控制。
TB control in India in the COVID era.
机构信息
Dept. of Pulmonary Medicine, WHO Collaborating Centre for Research & Capacity Building in Chronic Respiratory Diseases, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India; National Task Force (NTEP/RNTCP).
出版信息
Indian J Tuberc. 2021 Jan;68(1):128-133. doi: 10.1016/j.ijtb.2020.08.019. Epub 2020 Aug 28.
Abstract
COVID-19 pandemic has disturbed the delivery of health care in almost all countries of the world. This has affected mostly the public health control programs. Because of lock downs, restrictions in movement, psychological fear of contacting the disease in health care facilities, diversion of health care workers for containment and management of COVID-19, utilization of diagnostic facilities like CBNAAT machines for COVID work, conversion of hospitals for care of these patients, financial diversion etc has created issues in the NTEP to focuss on TB control in India. Case notification and other areas of the program to achieve End TB by 2025 have suffered. Various ways of overcoming these difficulties have been discussed.
摘要
COVID-19 大流行几乎扰乱了世界上所有国家的医疗保健服务提供。这主要影响了公共卫生控制计划。由于封锁、行动限制、在医疗保健机构接触疾病的心理恐惧、医护人员转移以遏制和管理 COVID-19、用于 COVID 工作的 CBNAAT 等诊断设施的利用、医院转为这些患者的护理、资金转移等，印度国家结核病控制项目（NTEP）在专注于结核病控制方面遇到了问题。病例报告和该项目的其他领域，以实现到 2025 年终止结核病的目标，都受到了影响。已经讨论了克服这些困难的各种方法。
相似文献
1
TB control in India in the COVID era.新冠疫情时代下的印度结核病控制。
Indian J Tuberc. 2021 Jan;68(1):128-133. doi: 10.1016/j.ijtb.2020.08.019. Epub 2020 Aug 28.
2
Tuberculosis management in India during COVID-19 crisis.印度在新冠疫情期间的结核病管理。
J Public Health Policy. 2021 Mar;42(1):185-189. doi: 10.1057/s41271-020-00265-8. Epub 2020 Nov 24.
3
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.评估新冠疫情管理对印度国家消除结核病计划中人力资源工作量的影响。
BMC Health Serv Res. 2024 Aug 7;24(1):907. doi: 10.1186/s12913-024-11131-8.
4
Care of tuberculosis patients in the times of COVID-19.COVID-19 时期的结核病患者护理。
Indian J Tuberc. 2021 Apr;68(2):285-286. doi: 10.1016/j.ijtb.2020.09.004. Epub 2020 Sep 5.
5
Impact of COVID-19 Pandemic on Tuberculosis Care and Treatment in Puducherry - A Mixed Method Study.COVID-19 大流行对本地治里结核病护理和治疗的影响-混合方法研究。
Indian J Public Health. 2023 Oct 1;67(4):626-631. doi: 10.4103/ijph.ijph_1406_22. Epub 2023 Dec 29.
6
TB care for women and Covid-A double health crisis in the offing?结核病护理与新冠：女性面临双重健康危机？
Health Care Women Int. 2020 Nov-Dec;41(11-12):1226-1239. doi: 10.1080/07399332.2020.1837135.
7
The effect of the Covid-19 pandemic on Tuberculosis (TB) case notification in Ogun State, Nigeria.新冠疫情对尼日利亚奥贡州结核病（TB）病例报告的影响。
Afr Health Sci. 2023 Sep;23(3):376-383. doi: 10.4314/ahs.v23i3.44.
8
Changing patterns of household transmission of tuberculosis in an eastern state of India: The impact of COVID19 pandemic.印度东部邦家庭传播结核病模式的变化：新冠疫情的影响。
Indian J Tuberc. 2022 Oct;69(4):682-689. doi: 10.1016/j.ijtb.2022.03.001. Epub 2022 Mar 11.
9
The untimely demise of the TB Free block model in the wake of coronavirus disease 2019 in India.2019年冠状病毒病在印度爆发后，“无结核病”街区模式过早夭折。
Trans R Soc Trop Med Hyg. 2020 Nov 6;114(11):789-791. doi: 10.1093/trstmh/traa067.
10
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.预测 COVID-19 大流行对结核病患者和结核病控制规划的影响。
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21. doi: 10.1186/s12941-020-00363-1.
引用本文的文献
1
Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.巴西、印度和南非在新冠疫情期间结核病医疗服务中断情况：基于模型的国家层面数据分析
PLOS Glob Public Health. 2025 Jan 7;5(1):e0003309. doi: 10.1371/journal.pgph.0003309. eCollection 2025.
2
Analyzing risk factors of tuberculosis using type-2 interval-valued trapezoidal fuzzy numbers with Einstein aggregation operators extended to MCDM.使用扩展到多准则决策的具有爱因斯坦聚合算子的2型区间值梯形模糊数分析结核病的风险因素。
Heliyon. 2024 Aug 12;10(16):e35997. doi: 10.1016/j.heliyon.2024.e35997. eCollection 2024 Aug 30.
3
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.评估新冠疫情管理对印度国家消除结核病计划中人力资源工作量的影响。
BMC Health Serv Res. 2024 Aug 7;24(1):907. doi: 10.1186/s12913-024-11131-8.
4
Impact of COVID-19 on child tuberculosis hospitalization.COVID-19 对儿童结核病住院的影响。
Tunis Med. 2024 Jul 5;102(7):410-414. doi: 10.62438/tunismed.v102i7.4923.
5
Epidemiological and Time Series Analysis of Tuberculosis with Prediction during COVID-19 Pandemic using ARIMA Model: A Study from Churu District of Rajasthan.使用ARIMA模型对COVID-19大流行期间结核病进行流行病学和时间序列分析及预测：来自拉贾斯坦邦楚鲁区的一项研究
Indian J Community Med. 2023 Nov-Dec;48(6):926-929. doi: 10.4103/ijcm.ijcm_681_22. Epub 2023 Dec 1.
6
Impact on Tuberculosis Notification During COVID-19 Pandemic in India: A Narrative Review.COVID-19大流行期间对印度结核病通报的影响：一项叙述性综述
Cureus. 2023 Aug 25;15(8):e44087. doi: 10.7759/cureus.44087. eCollection 2023 Aug.
7
Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria-A systematic review.2019冠状病毒病疫情及抗疫措施对结核病、病毒性肝炎、艾滋病病毒/艾滋病和疟疾的影响——一项系统评价
PLOS Glob Public Health. 2023 May 1;3(5):e0001018. doi: 10.1371/journal.pgph.0001018. eCollection 2023.
8
Tuberculosis and COVID-19: An epidemic submerged in the pandemic: A case series and review of current literature.结核病与新冠肺炎：大流行中被掩盖的一种流行病：病例系列及当前文献综述
J Family Med Prim Care. 2022 Oct;11(10):6576-6580. doi: 10.4103/jfmpc.jfmpc_258_22. Epub 2022 Oct 31.
9
Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts.结核分枝杆菌（TB）后遗症：在印度进行的一项混合 I 型有效性实施非劣效性随机试验的研究方案，比较两种在接受 TB 治疗的个体及其家庭接触者中进行的主动病例发现（ACF）策略。
Trials. 2022 Aug 5;23(1):635. doi: 10.1186/s13063-022-06503-6.
10
COVID-19: a boon or a bane for the microbiologists.新冠疫情：对微生物学家来说是福是祸。
Indian J Med Microbiol. 2022 Jan-Mar;40(1):7-11. doi: 10.1016/j.ijmmb.2021.12.020. Epub 2022 Jan 19.
本文引用的文献
1
Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.结核病和 COVID-19：从过去的病毒爆发中吸取教训和可能的未来结果。
Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020.
2
COVID-19: ensuring continuity of TB services in the private sector.2019冠状病毒病：确保私营部门结核病服务的连续性。
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):870-872. doi: 10.5588/ijtld.20.0400.
3
COVID-19 and tuberculosis-threats and opportunities.2019冠状病毒病与结核病——威胁与机遇
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):757-760. doi: 10.5588/ijtld.20.0387.
4
COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity' or 'death'.新冠病毒与结核病合并感染——堪称导致“重症”或“死亡”的完美“秘方”中的“点睛之笔”。
J Infect. 2020 Sep;81(3):e39-e40. doi: 10.1016/j.jinf.2020.06.062. Epub 2020 Jun 29.
5
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).传染病和大流行病病毒感染：对结核病和肺部的影响：世界传染病和免疫障碍协会（WAidid）、全球结核病网络（GTN）以及欧洲临床微生物学和传染病学会分枝杆菌感染研究组（ESGMYC）成员的共识。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.
6
The (in)significance of TB and COVID-19 co-infection.结核和 COVID-19 合并感染的意义。
Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.02105-2020. Print 2020 Aug.
7
Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.结核病与2型糖尿病：2019冠状病毒病时期的一种炎症危险信号
Clin Infect Dis. 2021 Jan 23;72(1):79-81. doi: 10.1093/cid/ciaa747.
8
Tuberculosis in the time of COVID-19: quality of life and digital innovation.COVID-19 时期的结核病：生活质量与数字创新。
Eur Respir J. 2020 Aug 6;56(2). doi: 10.1183/13993003.01998-2020. Print 2020 Aug.
9
Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.意大利某参考医院中 COVID-19 与活动性肺结核合并感染的临床特征。
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01708-2020. Print 2020 Jul.
10
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?南非应对严重急性呼吸综合征冠状病毒2：我们能从耐多药结核病中学到什么？
Eur Respir J. 2020 Jul 23;56(1). doi: 10.1183/13993003.01369-2020. Print 2020 Jul.
Zotero 插件